Jiangsu Hengrui Pharmaceuticals Co.,Ltd (SHA:600276)
China · Delayed Price · Currency is CNY 62.90
-0.66 (-1.04%)
Nov 14, 2025, 3:00 PM CST
Jiangsu Hengrui Pharmaceuticals Co.,Ltd Company Description
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.
It develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases.
The company was founded in 1970 and is headquartered in Lianyungang, China.
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
| Country | China |
| Founded | 1970 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 20,238 |
| CEO | Ji Feng |
Contact Details
Address: No. 38, Huanghe Road Lianyungang, Liaoning Province 222047 China | |
| Phone | 86 40 0828 3900 |
| Website | hengrui.com |
Stock Details
| Ticker Symbol | 600276 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE0000014W7 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Piao Yang Sun | Executive Chairman of the Board |
| Hong Bin Dai | Executive Deputy Chairman of the Board |
| Kin Chun Lau | Chief Financial Officer |
| Jie Ping Sun | Senior Vice President and Executive Director |
| Dr. Lian Shan Zhang Ph.D. | Executive Vice President and Executive Director |
| Dr. Ningjun Jiang M.D., Ph.D. | Executive Vice President, Chief Strategy Officer and Executive Director |
| Xiao Han Liu | Board Secretary |
| Ya Ping Shen | Deputy General Manager |
| Cheng Liao | Deputy General Manager |
| Feng He | Deputy General Manager |